![Anatol Kreitzer](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Anatol Kreitzer
Corporate Officer/Principal chez
MAPLIGHT THERAPEUTICS, INC.
Fortune : 6 M $ au 31/05/2026
Profil
Anatol Kreitzer is Chief Discovery Officer at MapLight Therapeutics, Inc. since 2020, with employment at the firm starting in 2019.
Formerly, Dr. Kreitzer was a Professor of Physiology and Neurology at the University of California.
Dr. Kreitzer earned a doctorate from Harvard University and completed undergraduate studies at the University of California, Berkeley.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 27/04/2026 | 211 190 ( 0,5% ) | 6 M $ | 31/05/2026 |
Postes actifs de Anatol Kreitzer
| Sociétés | Poste | Début |
|---|---|---|
| MAPLIGHT THERAPEUTICS, INC. | Corporate Officer/Principal | 01/06/2020 |
Anciens postes connus de Anatol Kreitzer
| Sociétés | Poste | Fin |
|---|---|---|
University of California
 University of California Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | - |
Formation de Anatol Kreitzer
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
5
Relations au 1er degré
4
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 4 |
|---|---|
Harvard University
 Harvard University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of California, Berkeley
 University of California, Berkeley Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of California
University of California Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
MapLight Therapeutics, Inc.
 MapLight Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage biopharmaceutical company that develops therapeutics for debilitating central nervous system disorders | Health Technology |
